US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Triamcinolone Acetonide cream

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0004-15 D-1106-2022
Class II · Moderate risk Terminated

Prednisolone Acetate Ophthalmic Suspension

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-637-05 D-1105-2022
Class II · Moderate risk Terminated

Pantoprazole Sodium for Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-3232-95 D-1104-2022
Class II · Moderate risk Terminated

Ondansetron HCL

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 65862-188-30 D-1103-2022
Class II · Moderate risk Terminated

Diphenhydramine HCl oral solution

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0121-0978-10 D-1101-2022
Class II · Moderate risk Terminated

Verapamil HCL

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-011-01 D-1100-2022
Class II · Moderate risk Terminated

Thrombin JMI

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-215-05 D-1099-2022
Class II · Moderate risk Terminated

Epinephrine

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-933-01 D-1098-2022
Class II · Moderate risk Terminated

Depo-Medrol

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3475-01 D-1097-2022
Class II · Moderate risk Terminated

Depo-Medrol

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0009-3073-03 D-1096-2022
Class II · Moderate risk Terminated

Bupivacaine Hydrochloride

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0409-1163-01 D-1095-2022
Class II · Moderate risk Terminated

Labetalol Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 49884-122-01 D-1094-2022
Class II · Moderate risk Terminated

Prazosin Hydrochloride Capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-1101-01 D-1093-2022
Class II · Moderate risk Terminated

Loperamide Hydrochloride capsules

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0378-2100-01 D-1092-2022
Class II · Moderate risk Terminated

Duraclon

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 67457-218-10 D-1091-2022
Class II · Moderate risk Terminated

Proventil HFA

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-1132-04 D-1090-2022
Class II · Moderate risk Terminated

Celestone Soluspan

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0085-4320-01 D-1089-2022
Class II · Moderate risk Terminated

Levofloxacin Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6352-61 D-1088-2022
Class II · Moderate risk Terminated

Kinevac

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-0556-15 D-1087-2022
Class II · Moderate risk Terminated

Gastrografin

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-0445-35 D-1086-2022
Class II · Moderate risk Terminated

E-Z-Gas II

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0270-9020-01 D-1085-2022
Class II · Moderate risk Terminated

E-Z-Hd

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 32909-764-01 D-1084-2022
Class II · Moderate risk Terminated

Transderm Scop

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 10019-553-03 D-1083-2022
Class II · Moderate risk Terminated

Recothrom Thrombin Topical

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0322-01 D-1082-2022